Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
COVID-19 and Cancer Immunotherapy
Email alerts
COVID-19 and Cancer Immunotherapy
JAK inhibitors and COVID-19
Gabriel
Levy
,
Paola
Guglielmelli
,
Peter
Langmuir
,
Stefan N
Constantinescu
Journal for ImmunoTherapy of Cancer
Apr 2022,
10
(4)
e002838;
DOI:
10.1136/jitc-2021-002838
Perspectives on COVID-19 and cancer immunotherapy: a review series
Jason D
Goldman
,
Paolo Antonio
Ascierto
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002489;
DOI:
10.1136/jitc-2021-002489
Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic
Renee N
Donahue
,
Jennifer L
Marté
,
Meghali
Goswami
,
Nicole J
Toney
,
Yo-Ting
Tsai
,
James L
Gulley
,
Jeffrey
Schlom
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002087;
DOI:
10.1136/jitc-2020-002087
Severity of COVID-19 in patients with lung cancer: evidence and challenges
Antonio
Passaro
,
Christine
Bestvina
,
Maria
Velez Velez
,
Marina Chiara
Garassino
,
Edward
Garon
,
Solange
Peters
Journal for ImmunoTherapy of Cancer
Mar 2021,
9
(3)
e002266;
DOI:
10.1136/jitc-2020-002266
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden T
Maecker
Journal for ImmunoTherapy of Cancer
May 2021,
9
(5)
e002550;
DOI:
10.1136/jitc-2021-002550
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy
Lorenzo
Iovino
,
Laurel A
Thur
,
Sacha
Gnjatic
,
Aude
Chapuis
,
Filippo
Milano
,
Joshua A
Hill
Journal for ImmunoTherapy of Cancer
May 2021,
9
(5)
e002392;
DOI:
10.1136/jitc-2021-002392
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin
Switzer
,
John
Haanen
,
Paul C
Lorigan
,
Igor
Puzanov
,
Samra
Turajlic
Journal for ImmunoTherapy of Cancer
Jul 2021,
9
(7)
e002835;
DOI:
10.1136/jitc-2021-002835
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
Emanuela
Romano
,
Steve
Pascolo
,
Patrick
Ott
Journal for ImmunoTherapy of Cancer
Jun 2021,
9
(6)
e002932;
DOI:
10.1136/jitc-2021-002932
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
Jason D
Goldman
,
Philip C
Robinson
,
Thomas S
Uldrick
,
Per
Ljungman
Journal for ImmunoTherapy of Cancer
Jun 2021,
9
(6)
e002630;
DOI:
10.1136/jitc-2021-002630
IL-6 modulation for COVID-19: the right patients at the right time?
Paolo Antonio
Ascierto
,
Binqing
Fu
,
Haiming
Wei
Journal for ImmunoTherapy of Cancer
Apr 2021,
9
(4)
e002285;
DOI:
10.1136/jitc-2020-002285
Special collections
COVID-19
(46)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(587)
Cancer Immunotherapy in Understudied Populations
(4)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(1020)
Commentary/Editorials
(159)
Computational I-O
(5)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(57)
Guidelines and Consensus Statements
(48)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(260)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(459)
Liquid Biopsies
(8)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(157)
Reviews
(251)
SITC 40th Anniversary: I-O Progress and Potential
(1)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(6587)
Press releases
(4)
